Haisco Pharmaceutical Group Co., Ltd.: all 155 studies

Page 1 of 2. Open to participants first (49), then studies with results posted, then the rest; newest registration first within each.

• HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal CancerRecruitingNCT07790510Phase 1/2
• Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07728721Phase 2
• HSK41959 With Standard Therapy in Solid Tumors With MTAP DeletionNot yet recruitingNCT07699757Phase 1
• A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid TumorsNot yet recruitingNCT07695142Phase 1
• A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPDNot yet recruitingNCT07658339Phase 3
• Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPDNot yet recruitingNCT07634367Phase 3
• A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA NephropathyRecruitingNCT07616700Phase 2
• A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis BronchiectasisRecruitingNCT07616375Phase 3
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPDRecruitingNCT07583849Phase 3
• A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASHRecruitingNCT07581951Phase 3
• First-in-human Study of HSK56630 in Healthy SubjectsRecruitingNCT07580794Phase 1
• Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 MutationRecruitingNCT07561554Phase 1
• A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryNot yet recruitingNCT07551739Phase 2
• A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal SurgeryRecruitingNCT07533786Phase 2
• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.RecruitingNCT07521345Phase 1
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07519070Phase 3
• HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective SurgeryNot yet recruitingNCT07510945Phase 3
• Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary FibrosisNot yet recruitingNCT07503587Phase 3
• Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPDNot yet recruitingNCT07425210Phase 2
• Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgANRecruitingNCT07390123Phase 3
• Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LNRecruitingNCT07363460Phase 2
• A Study for HSK47388 in Participants With Ulcerative ColitisRecruitingNCT07335055Phase 2
• A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's LymphomaRecruitingNCT07283796Phase 1
• Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 MutationRecruitingNCT07158710Phase 1
• A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque PsoriasisNot yet recruitingNCT07158268Phase 2
• Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic ImpairmentRecruitingNCT07152288Phase 1
• A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque PsoriasisNot yet recruitingNCT07150988Phase 2
• Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)RecruitingNCT07140328Phase 2
• Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy SubjectsEnrolling by invitationNCT07134465Phase 1
• A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 DiabetesNot yet recruitingNCT07122102Not applicable
• A Long-term Study of HSK44459 Tablets in Participants With Bechet's DiseaseNot yet recruitingNCT07070739Phase 2
• Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)Not yet recruitingNCT07019090Phase 2
• Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT07007910Phase 1
• Phase I Study of HSK41959 in Solid Tumors With MTAP DeletionRecruitingNCT06968572Phase 1
• This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy VolunteersNot yet recruitingNCT06926218Phase 1
• Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's DiseaseNot yet recruitingNCT06902428Phase 2
• A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus HypersecretionEnrolling by invitationNCT06820749Phase 2
• Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal HemoglobinuriaRecruitingNCT06745622Phase 2
• A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective SurgeryRecruitingNCT06740201Phase 4
• A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis BronchiectasisRecruitingNCT06660992Phase 3
• A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial AsthmaEnrolling by invitationNCT06637254Phase 2
• Phase I Study of HSK42360 in Solid Tumors With BRAF V600 MutationRecruitingNCT06536400Phase 1
• Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to PregabalinRecruitingNCT06490484Phase 2
• Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in ChinaNot yet recruitingNCT06422117Phase 3
• A Study for HSK39775 in Participants With Solid TumorsRecruitingNCT06314373Phase 1/2
• A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.Not yet recruitingNCT06290375Phase 2
• To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in ChinaRecruitingNCT06122012Not applicable
• Phase I Study of HSK40118 in NSCLC Patients With EGFR MutationRecruitingNCT06050980Phase 1
• A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal ImpairmentRecruitingNCT05947097Phase 1
• Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)CompletedNCT06795204Phase 1Results posted
• Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective SurgeryCompletedNCT05486416Phase 3Results posted
• Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General AnesthesiaCompletedNCT05478174Phase 3Results posted
• Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective SurgeryCompletedNCT04711837Phase 3Results posted
• Trial of HSK44459 Cream for the Management Plaque PsoriasisActive, not recruitingNCT07623486Phase 1/2
• Bioequivalence Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese SubjectsCompletedNCT07558967Phase 1
• Bioequivalence Study of Lidocaine and Prilocaine Cream in Healthy Chinese SubjectsCompletedNCT07551713Phase 1
• Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese SubjectsCompletedNCT07519278Phase 1
• A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryCompletedNCT07442877Phase 2
• Part 1: Dose-Finding of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant UsersCompletedNCT07404306Phase 1
• A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD PatientsActive, not recruitingNCT07331402Phase 2
• Food Effect Study of HSK47388 in Healthy SubjectsCompletedNCT07192692Phase 1
• A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryCompletedNCT07186426Phase 3
• Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy SubjectsActive, not recruitingNCT07134478Phase 1
• Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)Active, not recruitingNCT07108699Phase 2
• Bioequivalence Study of Propofol Medium and Long Chain Fat Emulsion Injection in Healthy Chinese SubjectsCompletedNCT07057609Phase 1
• Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese SubjectsCompletedNCT07054255Phase 1
• Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With AnemiaCompletedNCT07052838Phase 3
• A Study for HSK44459 in Participants With Atopic DermatitisActive, not recruitingNCT06996912Phase 2
• Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HSK39004 Dry Powder InhalationCompletedNCT06971198Phase 1
• Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Efficacy of HSK39004 Suspension for InhalationCompletedNCT06905847Phase 1
• A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy SubjectsCompletedNCT06858657Phase 1
• Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male SubjectsCompletedNCT06852092Phase 1
• A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor TherapyCompletedNCT06799546Phase 3
• Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary FibrosisCompletedNCT06764862Phase 2
• A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes PatientsCompletedNCT06703268Phase 2
• Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgANCompletedNCT06670352Phase 2
• A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPDCompletedNCT06643078Phase 3
• A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPDCompletedNCT06619210Phase 2
• Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.Active, not recruitingNCT06569784Phase 1
• A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria（PNH）CompletedNCT06561841Phase 2
• A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective SurgeryCompletedNCT06391931Phase 3
• A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK39297 in Healthy SubjectsCompletedNCT06350279Phase 1
• Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.Active, not recruitingNCT06258746Phase 1
• Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis PatientsCompletedNCT06238388Phase 1
• To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .CompletedNCT06168383Phase 2
• A Study to Evaluate the DDI of HSK7653 With MetforminCompletedNCT06084156Phase 1
• Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DMCompletedNCT06059326Phase 2
• HSK16149 for Perioperative Analgesia in Orthopedic SurgeryCompletedNCT06007066Phase 2
• Relative Bioavailability and Pharmacodynamics of HSK7653 in Healthy VolunteersCompletedNCT06003088Phase 1
• Single Escalating Dose Study Of HSK7653 In Healthy SubjectsCompletedNCT05983289Phase 1
• A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal ImpairmentCompletedNCT05916573Phase 1
• To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral NeuralgiaCompletedNCT05890053Phase 3
• The Drug-drug Interaction of HSK16149 Capsule With Probenecid Tablets or Cimetidine Tablets in Healthy SubjectsCompletedNCT05881811Phase 1
• Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers.CompletedNCT05835934Phase 1
• Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）CompletedNCT05795517Phase 2
• To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic NeuralgiaCompletedNCT05763550Phase 2
• A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dosed of HSK36273 in Healthy VolunteersCompletedNCT05742126Phase 1
• Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy VolunteersCompletedNCT05663593Phase 1
• Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant UsersCompletedNCT05614544Phase 1
• A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy SubjectsStatus unknownNCT05602129Phase 2

← Haisco Pharmaceutical Group Co., Ltd. overview and focus areas